TNFSF10 and neoplasm: According to in vivo analysis, after subcutaneous and intravenous injection of ATMSCs/TRAIL, these cells, without obvious side effects on normal organs, migrated to the tumor site, significantly induced apoptosis, and decreased tumor size (80).